We discuss a patient who developed severe renal tubular dysfunction secondary to short-term therapy with Amikacin, resulting in refractory hypokalemia, hypocalcemia, hypomagnesemia, metabolic alkalosis, and polyuria.
polyuria
Amikacin
refractory hypokalemia
Amikacin
severe renal tubular dysfunction
Amikacin
metabolic alkalosis
Amikacin
hypocalcemia
Amikacin
hypomagnesemia
Amikacin